- A new round of funding has been announced as part of the Government’s commitment to tackle health inequalities. NHS Blood and Transplant has, again, partnered with leading…
- Leading blood cancer and blood disorder charity Anthony Nolan has announced a new five-year strategy. Unlocking new ways to treat every patient, builds on the charity’s almost 50…
- Lord James O'Shaughnessy’s independent review into commercial clinical trials in the UK was published on Thursday 25 May. The IMPACT clinical trials network, joint funded…
- Anthony Nolan Cell Therapy and Laboratory Services is delighted to announce their newest partnership with start-up MicrofluidX. MicrofluidX will be developing its…
- Newly published research from blood cancer charity Anthony Nolan has shown that the youngest stem cell donors are as reliable as older stem cell donors, supporting Anthony Nolan’s…
- The UK will return to the European Union Horizon research programme, it has been announced. In response, Dr. Robert Danby, Chief Medical and Scientific Officer at stem…
- Following news today that medical regulators have approved a gene therapy with the potential to cure the blood disorders sickle cell disease and beta thalassemia, Yasmin Sheikh,…
- Today we celebrate the news that a new treatment for chronic Graft Vs Host Disease has been approved the National Institute for Health and Care Excellence (NICE). Belumosudil will…
- Anthony Nolan continues to invest in new blood cancer treatment innovations with a £1 million contribution to the new not-for-profit clinical trials organisation, ACT (…
- Stem cell charity Anthony Nolan welcomes the decision to make Casgevy (exa-cel) available to patients with the serious blood disorder thalassaemia, and calls for NICE to urgently…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.